Navigation Links
Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018
Date:11/9/2009

therapies -- the poly ADP-ribose polymerase (PARP) inhibitors. The PARP inhibitors represent a novel therapeutic strategy in DNA-repair-deficient tumors, such as triple-negative breast cancer.

"PARP inhibitors, which include Sanofi-Aventis's BSI-201 and AstraZeneca's olaparib, could dramatically improve prognoses for the woefully underserved patient subgroups with DNA-repair-deficient tumors," Dr. Murphy said.

About Decision Resources

Decision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Decision Resources            Decision Resources, Inc.
    Christopher Comfort           Elizabeth Marshall
    781-296-2597                  781-296-2563
    ccomfort@dresources.com       emarshall@dresources.com

SOURCE Decision Resources


'/>"/>
SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Recession Continues to Depress Sales at Allied Healthcare Products
2. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
3. Prasco Enters into Agreements with sanofi-aventis U.S. to Provide Sales Support and Distribution Services for Authorized Generic Versions Under the Winthrop Label in U.S.
4. DUSA Pharmaceuticals Surpasses One Million in Cumulative Levulan(R) Kerastick(R) Sales Units
5. Cephalon Net Sales Increase 9% and Net Cash from Operations Surpasses $200 Million in the Third Quarter 2009
6. HeartSine and Your Safety Company to Donate a Portion of Sales Proceeds to Sudden Cardiac Arrest Foundation
7. University Medical Pharmaceuticals Selects Jeffrey Ten as Senior Vice President, International Sales
8. Biosimilar Insulins and Insulin Analogues Stand to Erode $6.1 Billion in Brand Sales in the U.S. and Europe by 2018
9. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
10. $500 Billion Health Care Spend Boosts BRIC Countries Diagnostic Imaging Sales Despite Global Recession, According to Millennium Research Group
11. EUCODIS Bioscience Appoints Bhupinder Hundle to Senior Vice President Marketing & Sales

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...FirstCall/--HeskaCorporation(HSKA);("Heska"),alead...ctstotheveterinaryindustry,announcedtodayagreement...dgasproductsandaffiliatedconsumablesfortheveterina...bin/prnh/20000622/HESKALOGO ) ,, "HeskaandRoche...edpoint-of-carediagnostics,"commentedMichaelMcGinl...
(Date:11/25/2009)...TrendsResearchGroup,Inc.releasedWave1ofits Launch...asesyndicatedmarketresearchprojecttrackingthelaunc...hthroughthefirstsixmonthsofavailability.Eachwaveof...ueDermatologistsandqualitativeinformationfromasubs...lestouse,typicalpatienttypes,productperceptions,pr...
(Date:11/25/2009)...re/--RegadoBiosciences,aprivatelyheldcompanyleadin...ontrolagents,announcedthatDavidMazzo,PhD,CEOandPre...HealthCareConferenceattheNewYorkPalaceHotelinNewYo...ST)onTuesday,December1andwillincludeanoverviewofth...program,theanticoagulantsystem,REG1.Thehealthcarei...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Walking hazard 3A Cell phone use but not music reduces pedestrian safety 61422 1Walking hazard 3A Cell phone use but not music reduces pedestrian safety 61422 2The evolving manager stereotype 3A Gender a factor in measuring a teams performance 61420 17th International Chronic Total Occlusion Summit in New York City 61418 1
... MELBOURNE, Australia, May 03, 2007 /PRNewswire-Fi...nced today that the Company,intends to initiate a ...y and safety of the improved formulation of its tr...ing long-acting insulin.,The trial is expected to ...nsulin gel is being developed as a novel "needle-f...
...CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 3, 2007 - X...emonstrating that,Symadex(TM) reversed the clinica...animal model for multiple sclerosis. The presentat...r of Diagnostic,Radiology at the University of Wes...rchers from Xanthus in a poster session at the,59t...
Other Medicine Technology:Phosphagenics to Commence Phase 1b Transdermal Insulin Clinical,Trial in Second Quarter 2Xanthus Presents Novel Approach for Autoimmune Disease Reversal,with Symadex 2Xanthus Presents Novel Approach for Autoimmune Disease Reversal,with Symadex 3
(Date:11/25/2009)...eumatoid arthritis, could help newly diagnosed dia...25 (HealthDay News) -- A drug commonly used to tre... now also shows some promise in helping patients n..., rituximab (Rituxan), helped patients keep produc...ease had destroyed some of their pancreatic beta c...
(Date:11/25/2009)...ical symptoms, study finds , , WEDNESDA...ffects are among the potential problems faced by l...reated with cisplatin-based chemotherapy, a new st...gian men treated for unilateral testicular cancer ... survey conducted from 1998 to 2002. , The rese...
(Date:11/25/2009)...wire-USNewswire/--TheAmericanAssociationforHomecar....2128,whichisdesignedtosubstantiallyimprovetoolsan...lwasintroducedbySen.GeorgeLeMieux(R-Fla.). ,, T...ssociationforHomecareoutlinedinits13-pointanti-fra...inFebruary.Thoseprovisionsincludecallingforreal-ti...
(Date:11/25/2009)...ancer also can reverse a rare stomach disorder and...isease, researchers at Vanderbilt University Medic...auses thickening of the stomach lining, severe abd...a and swelling in the feet and ankles due to prote...c cancer. Previously, the only effective treatment...
(Date:11/25/2009)...hat mimicked parts of speech colored perception of...y News) -- People can "hear" not only with their e... , In fact, sensations on the skin designed to ...le decipher sounds better, the Canadian scientists...her we could use tactile information in this way,"...
Breaking Medicine News(10 mins):Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2Health News:Your Skin Can Help Your Ears Listen 2Health News:Your Skin Can Help Your Ears Listen 3
...est assesses osteoporosis risk and helps provide p...r bone health, CINCINNATI and BRIDGEWATER, N.J., ...tand your risk factors for osteoporosis, using a,n...test asks less than 20 simple questions about fami...
...nsecutive Year in Deloitte,s Technology Fast 50 Pr...stems,Inc. (Nasdaq: CASM ), a medical device comp... monitoring, today announced that it has been name...life sciences companies in the area by Deloitte & ...
...nt to Host Conference Call and Webcast Same Aftern...,BZI), a provider of functional foods, beverages a...he Company will report its financial and,operation...ernoon beginning at,4:15 PM Eastern Time, and invi...
...LIS, Oct. 19 Uroplasty, Inc. (Amex:,UPI) announce... with the,U.S. Securities and Exchange Commission ...10,000,000 (exclusive of over-allotment option) of...ic offering.,A copy of the prospectus relating to ...
...xis to Demonstrate Advanced Coronary & Peripheral ...ping at TCT 2007 Stereotaxis, Mobile Vasc...Stereotaxis, Inc. (Nasdaq:,STXS) announced today t...erapeutics (TCT) symposium in Washington,D.C., Oct...
...UGE, La., Oct. 19 Amedisys, Inc.,(Nasdaq: AMED or...lth,nursing companies, today announced that it int...ter ended September 30, 2007 pre-market on Tuesday...onference call, please dial 800-683-1525,(Domestic...
Other Medicine News:Health News:Sixty Seconds That Can Change Your Life 2Health News:Sixty Seconds That Can Change Your Life 3Health News:Sixty Seconds That Can Change Your Life 4Health News:Sixty Seconds That Can Change Your Life 5Health News:CAS Medical Systems, Inc. Ranked Among Connecticut's Fastest Growing Technology Companies 2Health News:CAS Medical Systems, Inc. Ranked Among Connecticut's Fastest Growing Technology Companies 3Health News:CAS Medical Systems, Inc. Ranked Among Connecticut's Fastest Growing Technology Companies 4Health News:XELR8 Holdings to Announce 2007 Third Quarter Results on Wednesday, October 31, 2007 2Health News:XELR8 Holdings to Announce 2007 Third Quarter Results on Wednesday, October 31, 2007 3Health News:Uroplasty, Inc. Announces Filing of Registration Statement for Offering of Common Stock 2Health News:Uroplasty, Inc. Announces Filing of Registration Statement for Offering of Common Stock 3Health News:Stereotaxis Showcases Interventional Cardiology Capabilities of Niobe Magnetic Navigation System 2Health News:Stereotaxis Showcases Interventional Cardiology Capabilities of Niobe Magnetic Navigation System 3Health News:Stereotaxis Showcases Interventional Cardiology Capabilities of Niobe Magnetic Navigation System 4Health News:Amedisys to Host Conference Call to Discuss Third Quarter Financial Performance and Operating Results 2
...iratory Products, ,Westmed designs, manufacturers...nesthesia and Respiratory professionals. Our missi...nce the clinician's ability to deliver quality med...om line. , ,Our web site is designed with our cus...
...ge group?, ,Babies and young children have troubl...f an MDI. , ,Dry powder devices require a high mi... , ,Traditional nebulizers have high wastage and ...or this age group are inefficient at delivering me...
...Compressor is for active patients who want to take... The compressor is small and lightweight, yet powe...e AC compatibility (100 to 240V), 12 volt DC and r...o take aerosol treatments away from home, in their...
...Compressor is for active patients who want to take... The compressor is small and lightweight, yet powe...e AC compatibility (100 to 240V), 12 volt DC and r...o take aerosol treatments away from home, in their...
Medicine Products: